Nlrp3 inflammasome in expressed prostatic secretions as a potential biomarker of chronic prostatitis/chronic pelvic pain syndrome

HIGHLIGHTS

• What: The ROC curve analysis was conducted to evaluate the diagnostic potential of NLRP3 in EPS as a possible biomarker for CP/CPPS. The research examined the correlation between the expression of NLRP3 in EPS and the severity of CP/CPPS.
• Who: Ma C-G from the Department of Urology, Tianjin Medical University Baodi Hospital, China have published the Article: NLRP3 inflammasome in expressed prostatic secretions as a potential biomarker of chronic prostatitis/chronic pelvic pain syndrome, in the Journal: (JOURNAL)
• How: One-way analysis of variance (ANOVA) or the Kruskal-Wallis test . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.